Tumour cell burden was readily apparent within control nu/nu mice treated with tumour cells 7 days post injection, along with tumour cells treated with targeted or nontargeted particles in the absence of TRAIL treatment (Fig. 5d). This evidence concerns the gene TNFSF10 and neoplasm.